Google DeepMind highlights five years of AlphaFold impact and Nobel Prize recognition, underscoring its transformative role.

Japan researchers used AlphaFold to characterize unusual hot-spring viruses, revealing a previously unknown family and informing our understanding of molecular evolution and biodiversity.

Singaporean scientists visualized a Parkinson’s-linked protein with AlphaFold, uncovering immune system interactions and enabling earlier diagnosis and targeted therapies.

Korea's KAIST team, led by Professor Ji-Joon Song, used AlphaFold to map hidden regions of a key cancer-related protein, uncovering a new interaction site and highlighting AlphaFold as foundational to structural biology.

AlphaFold is reshaping biological research by democratizing access to protein structure data, accelerating drug development and therapeutic innovation across the Asia-Pacific region, and serving as a catalyst for discovery in medicine, disease mechanisms, and evolutionary biology.

Globally adopted by more than three million researchers, AlphaFold’s influence is especially pronounced in APAC, where it is accelerating breakthroughs and redefining how biology and medicine are studied.

In Malaysia, Dr. Su Datt Lam’s team at the National University of Malaysia uses AlphaFold to study Burkholderia pseudomallei proteins, advancing drug development against melioidosis, the so-called silent killer.

Taiwan’s Academia Sinica team, using AlphaFold, predicted a novel 71-torus knot protein fold and later confirmed it experimentally, illustrating AlphaFold’s power to reveal new biological phenomena.

The five stories together show AlphaFold’s impact across neglected diseases, diagnostics, cancer biology, novel protein science, and evolutionary biology, contributing to broader scientific recognition including Nobel Prize context.

Experts describe AlphaFold as transformative for structural biology and science, likening it to an internet for structural biology that makes complex data accessible and interpretable.

Over a third of AlphaFold’s global user base now operates in APAC, signaling significant regional impact five years after rollout.

In Malaysia, AlphaFold enables rapid modeling of pathogen proteins like Burkholderia pseudomallei to speed up treatments for melioidosis, reducing experimental bottlenecks.